Risk Stratification Value of Biomarkers in Patients With Myocarditis
ConditionMyocarditis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-80
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
About this trial
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients should meet the diagnostic criteria for myocarditis
Patients who are regularly followed up at the corresponding cardiovascular center
Disqualifiers
Age <3 years or >80 years
Pregnant or lactating women
The patient refused to sign the informed consent and refused to participate in the study
None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent
Trial population
All hospitalized patients who meet the diagnostic criteria for myocarditis and undergo regular follow-up at the corresponding cardiovascular center are included in the study.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: Myocarditis group
Trial outcomes
Primary outcomes
1
Change in the incidence of MACCE
MACE (major adverse cardiovascular events) including all-cause death, myocardial infarction, stroke and coronary revascularization surgery. The MACCE will be assessed from the medical records.
Time frame
1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.Secondary outcomes
1
Change in the incidence of all-cause death
All-cause death diagnosed by clinical doctors will be assessed from the medical records
Time frame
1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.2
Change in the incidence of myocardial infarction
Myocardial infarction diagnosed by clinical doctors will be assessed from the medical records
Time frame
1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.3
Change in the incidence of stroke
Stroke diagnosed by clinical doctors will be assessed from the medical records
Time frame
1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.4
Change in the incidence of coronary revascularization surgery
Coronary revascularization surgery completed by clinical doctors will be assessed from the medical records
Time frame
1, 3, 6 months after enrollment; and 1, 2, 3, 4, 5 years after enrollment.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov